|Bid||62.13 x 100|
|Ask||89.95 x 100|
|Day's Range||80.76 - 81.62|
|52 Week Range||78.42 - 102.06|
|PE Ratio (TTM)||-24.10|
|Earnings Date||Oct 25, 2017 - Oct 30, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||112.47|
Evercore ISI analyst Josh Schimmer is bullish on biotech.
Gilead Sciences' CEO hints that buying a biotech with an oncology focus might not happen. Here's what this could mean for the big biotech.
- Citi's 12th Annual Biotech Conference on September 6 in Boston - Baird's 2017 Global Healthcare Conference on September 7 in New York - Morgan Stanley 15th Annual Global Healthcare Conference on September ...